Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "HAB"

259 News Found

PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Phablecare acquires Fused Training, a startup combating Type-1 Diabetes
Startup | March 31, 2022

Phablecare acquires Fused Training, a startup combating Type-1 Diabetes

Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management


Kypros Nicolaides Fetal Medicine centre opens in Abu Dhabi
Hospitals | March 22, 2022

Kypros Nicolaides Fetal Medicine centre opens in Abu Dhabi

Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia


G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research
Biotech | December 29, 2021

G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research

G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE


ShardaCare provides medical support at 30th Pre-UP State Shooting Championship 2026
Hospitals | June 09, 2026

ShardaCare provides medical support at 30th Pre-UP State Shooting Championship 2026

As official healthcare partner, ShardaCare deployed dedicated medical teams, emergency services, and on-site healthcare infrastructure


Bayer brings Alka-Seltzer to India touting first antacid with probiotic support
News | June 09, 2026

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support

The launch comes against the backdrop of a significant public health burden


Awshad launches Calmagummies Gold to tap cannabis-based wellness market
Healthcare | June 08, 2026

Awshad launches Calmagummies Gold to tap cannabis-based wellness market

Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery


Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
Medical Device | June 05, 2026

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
Drug Approval | June 01, 2026

Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections

The approval marks a major milestone in the global fight against antimicrobial resistance